Ind-Swift Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.0 pts less than Nifty Microcap 250 and 4.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Ind-Swift Laboratories Limited has filed its financial results for the quarter and half-year ended September 30, 2025 with the stock exchange. This is a standard regulatory filing disclosure under listing obligations. The actual numbers, including revenue, profit, margins, and auditor observations, are contained in the detailed results document, which has not been provided here. Investors should refer to the full results PDF for figures and any auditor remarks. No specific financial highlights, growth rates, or exceptional items can be confirmed from the filing notice alone.
This announcement is a routine compliance update confirming that quarterly results have been filed; it does not itself indicate any positive or negative development for the stock. The real impact will depend on the actual numbers and any auditor qualifications in the detailed results.